Medicare & MedicaidBack to stories →
← Back to stories
Coverage & clinical policyNew in this edition

Noridian opens five proposed LCDs for comments through November 14

Noridian opens five October 1 proposed LCDs for comments through November 14, without finalizing coverage criteria.

What happened

Noridian’s October 1 JE notice opens a comment period through November 14 for five proposed LCDs: automated brain-MRI detection and quantification DL40454, surgical nail treatment DL40462, knee osteoarthritis hyaluronic-acid injections DL40456, bacterial-presence fluorescence wound imaging DL40441 and near-infrared spectroscopy for wound and flap management DL40458. The notice identifies the applicable JE contract numbers, including California, Hawaii and the Pacific territories, and Nevada. Each topic has its own proposal and clinical scope despite the shared comment window.

Noridian directs readers to the Medicare Coverage Database for the proposed documents and asks submissions to identify the specific policy, with email and mail details on its proposed-LCD page. As of October 4, these remain proposals under review. The posting does not itself impose final restrictions, establish an effective coverage date or demonstrate that every service named will receive the same treatment. A useful organizational response should compare the relevant proposal with actual clinical evidence and workflows before making any recommendation to change current coverage or billing.

Scope and timing

Authority status
Proposed
Applicability
Operationally relevant
Audience
Health systems, Provider networks
Jurisdiction
Federal
Affected functions
Revenue Cycle, Compliance, Clinical Operations
Responsible owner
Revenue Cycle
Recorded date
2026-11-14
Date type
comment

Why it matters

Affected clinical and billing owners have an opportunity to address specific evidence and operational concerns before final policy decisions.

Implementation playbook

  1. Route the five policy proposals to the affected clinical and billing owners and decide whether to submit evidence before November 14. Revenue Cycle · Due 2026-11-14
  2. Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · Due 2026-10-12

Sources

Complete edition and supplemental material

This finding in the complete approved report →

Regulatory horizons, CIA trends and implementation trackers remain in the full report.

Read the entire Medicare & Medicaid report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies